INVESTORS

We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Neuropathix. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
100+ SKUs
Across 12 Brands
40+ COUNTRY DISTRIBUTION
Health Authority Approval in Mexico and Brazil
$46.9M 2020 REVENUE
Margins Over 75%
6 COMPANIES IN PORTFOLIO
Serving Consumer, B2B, Pharmaceutical Markets
OUR HISTORY
What Makes Us A Company of Firsts®
MORE ABOUT US
Get to Know Our Team and Portfolio
PRESS RELEASES
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
New Products Offer 3,000mg to 6,000mg, Will Come in Jars of 30 and 60mL, Presenting Significant...
Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
Direct Selling Subsidiary Taps Network Marketing Legends to Lead Communication and Information...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
SAN DIEGO, CA, Nov. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC:...
MEDIA COVERAGE
Medical Marijuana, Inc. Subsidiary HM Pharma Submits CBD Product Dossier; Receives Sanitary Registration in Brazil
SAN DIEGO, CA, Aug. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC:...
Medical Marijuana, Inc. CEO Provides Insight on Future of U.S. Cannabis Market in Nasdaq News
SAN DIEGO, CA, July 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC:...
Blake Schroeder, MJNA CEO, Joins Executive Panel Discussing “Making Sense Of Cannabis Stocks”
Medical Marijuana, Inc. CEO Mr. Blake Schroeder joins an executive panel discussion that makes...
STOCK INFO
LAST | 0.0265 | Change | -0.0005 |
OPEN | 0.0200 | Change % | 1.85% |
HIGH | 0.0287 | 52 Week Range | 0.01-0.222 |
LOWW | 0.0200 | Day Range | 0.0200-0.0287 |
VOLUME | 15119948 | Market Cap (real-time) | N/A |
Last Updated: 08-20-2021 (US/Eastern)